Tracer library / [123I]MIBG
Structure of 3-Iodobenzylguanidine (unlabelled parent compound, from PubChem)
Unlabelled parent compoundPubChem CID 60860

[123I]MIBG

Also written as I-123 MIBG; I-123-MIBG; MIBG
Radionuclide
I-123 t½ 792 min
Modality
SPECT
Production route
—
Stage
—
Syntheses indexed
1
Cardiac sarcoidosis and inflammationDementia other than Alzheimer'sParkinsonian syndromes and movement disordersNeuroendocrine neoplasmsCardiac sympathetic innervation / autonomic dysfunction

What it is

Compound class
radioiodinated benzylguanidine (norepinephrine analogue)
Target / mechanism
Norepinephrine transporter-mediated uptake into sympathetic nerve terminals (noradrenergic/adrenergic system imaging) PMID 40262827
Clinical application
Diagnostic imaging of cardiac sympathetic innervation and neuroendocrine tumours (pheochromocytoma/paraganglioma, neuroblastoma) using [123I]MIBG SPECT/scintigraphy PMID 34023989
Theranostic pair
[131I]MIBG

Published syntheses

ModuleCassettePurificationYield %RCP %Precursor / supplierSource
Manual synthesis—————9649115
1998 Br J Cancer
Using a no-carrier-added synthesis route, we produced 123I-, 125I-, 131I- and 211At-labelled benzylguanidines

Clinical literature

Clinical studies in the indexed corpus, ordered by design (multicentre, prospective, retrospective, others, case reports last) and then by year. Titles and links only, as published; this is not a summary of the evidence.

  1. REM sleep without atonia thresholds are associated with reduced cardiac MIBG uptake but not with DAT-SPECT binding in probable REM sleep behavior.
    2026 · Sleep Med · Multicentre
  2. Diagnosis and treatment of paragangliomas and pheochromocytomas: a survey from the Italian Association for Neuroendocrine Tumors.
    2025 · Front Endocrinol (Lausanne) · Multicentre
  3. Role of Functional Neuroimaging with 123I-MIBG and 123I-FP-CIT in De Novo Parkinson's Disease: A Multicenter Study.
    2023 · Life (Basel) · Retrospective, multicentre
  4. SGLT2-inhibitors reduce the cardiac autonomic neuropathy dysfunction and vaso-vagal syncope recurrence in patients with type 2 diabetes mellitus: the SCAN study.
    2022 · Metabolism · Prospective, multicentre
  5. An open-label, single-arm, multi-center, phase II clinical trial of single-dose [131I]meta-iodobenzylguanidine therapy for patients with refractory pheochromocytoma and paraganglioma.
    2022 · Ann Nucl Med · Multicentre · Phase II
  6. Meta-iodobenzylguanidine myocardial scintigraphy in Perry disease.
    2021 · Parkinsonism Relat Disord · Multicentre
  7. Impact of 123I-MIBG Scintigraphy on Clinical Decision-Making in Pheochromocytoma and Paraganglioma.
    2019 · J Clin Endocrinol Metab · Retrospective, multicentre
  8. hNET-targeted [18F]MFBG PET as baseline functional imaging in newly diagnosed neuroblastoma.
    2026 · Theranostics · Prospective
  9. Improvements of cardiac function and metabolic parameters by sodium-glucose cotransporter 2 inhibitors with no significant effects on sympathetic or parasympathetic activity in chronic heart failure.
    2026 · Heart Vessels · Prospective
  10. Effect of tofogliflozin on cardiac sympathetic nerve activity in type 2 diabetes mellitus patients with heart failure (TARGET-HF): rationale and design of the single-arm intervention trial.
    2025 · Cardiovasc Diabetol Endocrinol Rep · Prospective
Show all 126 clinical studies
  1. Feasibility of a single-day protocol for SPECT and PET assessment of dopamine transporter availability, cardiac innervation and metabolic patterns in patients with movement disorders.
    2025 · Eur J Nucl Med Mol Imaging · Prospective
  2. Performing [18F]MFBG Long-Axial-Field-of-View PET/CT Without Sedation or General Anesthesia for Imaging of Children with Neuroblastoma.
    2024 · J Nucl Med · Prospective
  3. [18F]MFBG PET/CT outperforming [123I]MIBG SPECT/CT in the evaluation of neuroblastoma.
    2023 · Eur J Nucl Med Mol Imaging · Prospective
  4. [18F] MFBG PET imaging: biodistribution, pharmacokinetics, and comparison with [123I] MIBG in neural crest tumour patients.
    2023 · Eur J Nucl Med Mol Imaging · Prospective
  5. Quality and utility of [123I]I-metaiodobenzylguanidine cardiac SPECT imaging in nondiabetic postinfarction heart failure patients qualified for implantable cardioverter defibrillator.
    2021 · Ann Nucl Med · Prospective
  6. Usefulness of 5 Minutes 123I-mIBG Scan in Parkinson's Disease and Heart Failure.
    2020 · Curr Radiopharm · Prospective
  7. Early effects of transcatheter aortic valve replacement on cardiac sympathetic nervous function assessed by 123I-metaiodobenzylguanidine scintigraphy in patients with severe aortic valve stenosis.
    2020 · Eur J Nucl Med Mol Imaging · Prospective
  8. Clinical, Diagnostic, and Treatment Characteristics of SDHA-Related Metastatic Pheochromocytoma and Paraganglioma.
    2019 · Front Oncol · Prospective, retrospective
  9. An FDG-first functional imaging approach in phaeochromocytoma and paraganglioma.
    2026 · Front Endocrinol (Lausanne) · Retrospective
  10. Clinical Characteristics and Diagnostic Pitfalls of Pheochromocytoma: A Pathology-Confirmed Retrospective Study From a Single Japanese Center.
    2026 · Cureus · Retrospective
  11. Potential usefulness of [123I]I-MIBG SPECT/CT with AC Quant protocols in diagnostics and treatment monitoring of children with neuroblastoma.
    2026 · Nucl Med Rev Cent East Eur · Retrospective
  12. Stratifying risk of heart failure death and arrhythmic events: a ¹²³I-meta-iodobenzylguanidine-based multinomial logistic model.
    2026 · Eur J Nucl Med Mol Imaging · Retrospective
  13. Metastatic Pheochromocytoma/Paraganglioma: Diagnostic Performance of Functional Imaging (18F-Fluoro-L-DOPA-, 68Ga-DOTA- and 18F-Fluoro-Deoxyglucose-Based PET/CT) and of 123I-MIBG Scintigraphy in 57 Patients and 527 Controls During Long-Term Follow-Up.
    2025 · Cancers (Basel) · Retrospective
  14. Semi-quantitative MIBG scores in relapsed/refractory neuroblastoma: Prognostic insights from post-131I-MIBG treatment scans and impact of SPECT-CT imaging.
    2025 · Rev Esp Med Nucl Imagen Mol (Engl Ed) · Retrospective
  15. The prognostic significance of semi-quantitative metabolic parameters and tumoral metabolic activity based on 123I-MIBG SPECT/CT in pretreatment neuroblastoma patients.
    2025 · Cancer Imaging · Retrospective
  16. Characterization of metabolic and imaging profiles in the diagnosis of succinate dehydrogenase- related hereditary pheochromocytomas and paragangliomas.
    2025 · Urol Oncol · Retrospective
  17. Indicative biomarkers of Lewy body disease as predictors of treatment resistance in late-onset depression.
    2025 · Int Psychogeriatr · Retrospective
  18. Associations of cerebrospinal fluid monoamine metabolites with striatal dopamine transporter binding and 123I-meta-iodobenzylguanidine cardiac scintigraphy in Parkinson's disease: Multivariate analyses.
    2024 · Parkinsonism Relat Disord · Retrospective
  19. Diagnostic Sensitivity and Symptomatic Relevance of Dopamine Transporter Imaging and Myocardial Sympathetic Scintigraphy in Patients with Dementia with Lewy Bodies.
    2024 · J Alzheimers Dis · Retrospective
  20. Sex differences in 123I-mIBG scintigraphy imaging techniques in patients with heart failure.
    2023 · Expert Rev Med Devices · Retrospective
  21. Evaluation of iodine-123-labeled metaiodobenzylguanidine single-photon emission computed tomography/computed tomography based on the International Society of Pediatric Oncology Europe Neuroblastoma score in children with neuroblastoma.
    2023 · Quant Imaging Med Surg · Retrospective
  22. 68Ga-DOTATATE PET in Restaging and Response to Therapy in Neuroblastoma: A Case Series and a Mini Review.
    2023 · J Nucl Med Technol · Retrospective
  23. Asphericity of tumor [123 I]mIBG uptake as a prognostic factor in high-risk neuroblastoma.
    2022 · Pediatr Blood Cancer · Retrospective
  24. Intrasubject relationship between striatal 18F-FP-CIT uptake and cardiac 123I-MIBG uptake differs by motor subtype in early Parkinson disease.
    2021 · Medicine (Baltimore) · Retrospective
  25. Image-Guided Biopsy for Relapsed Neuroblastoma: Focus on Safety, Adequacy for Genetic Sequencing, and Correlation of Tumor Cell Percent With Quantitative Lesion MIBG Uptake.
    2021 · JCO Precis Oncol · Retrospective
  26. Association between neurosarcoidosis with autonomic dysfunction and anti-ganglionic acetylcholine receptor antibodies.
    2021 · J Neurol · Retrospective
  27. A diagnostic strategy for Lewy body disease using DAT-SPECT, MIBG and Combined index.
    2020 · Ann Nucl Med · Retrospective
  28. MIBG myocardial scintigraphy in progressive supranuclear palsy.
    2019 · J Neurol Sci · Retrospective
  29. Different uptake of 123I-MIBG in the two main liver lobes: A persistant unsolved mistery.
    2018 · Rev Esp Med Nucl Imagen Mol (Engl Ed) · Retrospective
  30. Validation of 2-year 123I-meta-iodobenzylguanidine-based cardiac mortality risk model in chronic heart failure.
    2018 · Eur Heart J Cardiovasc Imaging · Retrospective
  31. SPECT/CT MIBG Imaging Is Crucial in the Follow-up of the Patients With High-Risk Neuroblastoma.
    2018 · Clin Nucl Med · Retrospective
  32. A case of neurofibromatosis type 1 with malignant peripheral nerve sheath tumor and metastatic pheochromocytoma.
    2026 · JCEM Case Rep · Clinical study
  33. False Positive Uptake of 123I-MIBG in Celiac Ganglion in a Patient With Neuroblastoma.
    2026 · Clin Nucl Med · Clinical study
  34. Decreased Myocardial 123I-MIBG Uptake Without Sympathetic Denervation: An Autopsy Report of Autoimmune Autonomic Ganglionopathy.
    2026 · Brain Behav · Clinical study
  35. An auxiliary 18F-FDG uptake pattern clarifying equivocal adrenal gland mass after dual-tracer imaging with 123I-mIBG SPECT/CT and 18F-FDG PET/CT.
    2026 · Hell J Nucl Med · Clinical study
  36. 123I-MIBG Scintigraphy-negative Pheochromocytoma without Hypertension Found During Follow-up for Non-functioning Adrenal Incidentaloma.
    2026 · Intern Med · Clinical study
  37. Pitfalls in diagnosing neuroblastoma: a case of unusual "adrenal tumor" accumulating [123I]I -MIBG.
    2025 · Nucl Med Rev Cent East Eur · Clinical study
  38. Phase II pilot randomized trial of zonisamide for disease modification in prodromal Lewy body disease.
    2025 · NPJ Parkinsons Dis · Clinical study · Phase II
  39. Three cases of gastrointestinal stromal tumors with metaiodobenzylguanidine (MIBG) accumulation.
    2025 · Fukushima J Med Sci · Clinical study
  40. Late-life parkinsonism in bipolar disorder.
    2025 · Psychogeriatrics · Clinical study
  41. False-Positive Uptake of 123 I-MIBG in the Basal Ganglion in a Pediatric Neuroblastoma Patient.
    2025 · Clin Nucl Med · Clinical study
  42. Association between sebum secretion and cardiac sympathetic dysfunction in Parkinson's disease.
    2024 · Parkinsonism Relat Disord · Clinical study
  43. Case Series: ATRX Variants in Four Patients with Metastatic Pheochromocytoma.
    2024 · Front Endocrinol (Lausanne) · Clinical study
  44. Usefulness of the Primary Tumor Standardized Uptake Value of Iodine-123 Metaiodobenzylguanidine for Predicting Metastatic Potential in Pheochromocytoma and Paraganglioma.
    2024 · Mol Imaging Biol · Clinical study
  45. Potential dopaminergic deficit in patients with geriatric psychiatric disorders as revealed by DAT-SPECT: a cross-sectional study.
    2024 · BMJ Ment Health · Clinical study
  46. [A case of left posterior cortical atrophy presenting with kana-predominant reading impairment].
    2024 · Rinsho Shinkeigaku · Clinical study
  47. Evaluation of pharmacokinetics, safety, and efficacy of [211At] meta-astatobenzylguanidine ([211At] MABG) in patients with pheochromocytoma or paraganglioma (PPGL): A study protocol.
    2024 · PLoS One · Clinical study
  48. 3-[18F]Fluoro-para-hydroxyphenethylguanidine (3-[18F]pHPG) PET-A Novel Imaging Modality for Paraganglioma.
    2024 · J Endocr Soc · Clinical study
  49. Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
    2024 · Clin Nucl Med · Clinical study
  50. Clinical characteristics of patients with Parkinson's disease with reduced 123I-metaiodobenzylguanidine uptake in the major salivary glands and heart.
    2024 · J Neurol Sci · Clinical study
  51. [Not Available].
    2024 · Nucl Med Mol Imaging · Clinical study
  52. Study Protocol for the Pleiotropic Effects of Sodium-Glucose Cotransporter 2 Inhibitor on Organ-Specific Sympathetic Nerve Activity and Insulin Sensitivity in Participants with Type 2 Diabetes.
    2024 · Diabetes Ther · Clinical study
  53. Nuclear Imaging Data-Driven Classification of Parkinson's Disease.
    2023 · Mov Disord · Clinical study
  54. Serial Nigrostriatal Dopaminergic Imaging in Mild Cognitive Impairment With Lewy Bodies, Alzheimer Disease, and Age-Matched Controls.
    2023 · Neurology · Clinical study
  55. Occipital hypometabolism is a risk factor for conversion to Parkinson's disease in isolated REM sleep behaviour disorder.
    2023 · Eur J Nucl Med Mol Imaging · Clinical study
  56. Lorlatinib with or without chemotherapy in ALK-driven refractory/relapsed neuroblastoma: phase 1 trial results.
    2023 · Nat Med · Clinical study · Phase I
  57. False-positive 123I-metaiodobenzylguanidine scintigraphy in a patient with a gastrointestinal stromal tumor presenting as a left adrenal incidentaloma.
    2023 · Endocrinol Diabetes Metab Case Rep · Clinical study
  58. Systemic Metabolic Alteration Dependent on the Thyroid-Liver Axis in Early PD.
    2023 · Ann Neurol · Clinical study
  59. Association of plasma α-synuclein with cardiac 123I-MIBG scintigraphy in early Parkinson's disease.
    2022 · Neurosci Lett · Clinical study
  60. Rapid Eye Movement Sleep Behavior Disorder: Abnormal Cardiac Image and Progressive Abnormal Metabolic Brain Pattern.
    2022 · Mov Disord · Clinical study
  61. Aceruloplasminemia: a multimodal imaging study in an Italian family with a novel mutation.
    2022 · Neurol Sci · Clinical study
  62. Potential for Increasing Uptake of Radiolabeled 68Ga-DOTATOC and 123I-MIBG in Patients with Midgut Neuroendocrine Tumors Using a Histone Deacetylase Inhibitor Vorinostat.
    2021 · Cancer Biother Radiopharm · Clinical study
  63. 123I metaiodobenzylguanidine (MIBG) uptake predicts early relapse of neuroblastoma using semi-quantitative SPECT/CT analysis.
    2021 · Ann Nucl Med · Clinical study
  64. Reduced Myocardial Uptake of 123I-MIBG in Congenital Insensitivity to Pain With Anhidrosis.
    2021 · Clin Nucl Med · Clinical study
  65. Two Cases of Decreased 123I-Metaiodobenzylguanidine Lung Uptake in Metaiodobenzylguanidine Scintigraphy While Taking Selective Serotonin Reuptake Inhibitor/Serotonin Noradrenaline Reuptake Inhibitor.
    2021 · Clin Nucl Med · Clinical study
  66. Elevated 123I-MIBG Activity in Intramuscular Hemangioma.
    2021 · Clin Nucl Med · Clinical study
  67. Cardiac 123I-MIBG normal uptake values are population-specific: Results from a cohort of controls over 60 years of age.
    2021 · J Nucl Cardiol · Clinical study
  68. Clinical relevance of 18F-FDG PET/CT in the postoperative follow-up of patients with history of medullary thyroid cancer.
    2020 · Radiol Oncol · Clinical study
  69. Comparison of 123I-MIBG scintigraphy and phosphorylated α-synuclein skin deposits in synucleinopathies.
    2020 · Parkinsonism Relat Disord · Clinical study
  70. Brain-first versus body-first Parkinson's disease: a multimodal imaging case-control study.
    2020 · Brain · Clinical study
  71. Misdiagnosis of Paraganglioma by 123I-mIBG Without Stable Iodine Blockade of Thyroidal Radioiodine Uptake.
    2020 · J Endocr Soc · Clinical study
  72. Cardiac sympathetic denervation in wild-type transthyretin amyloidosis.
    2020 · Amyloid · Clinical study
  73. Noradrenergic uptake in the liver on 123 I-mIBG imaging: Influence of heart failure and diabetes.
    2020 · J Gastroenterol Hepatol · Clinical study
  74. Differences in correlations of depression and anhedonia with cardiovascular sympathetic functions during a head-up tilt test in drug-naïve Parkinson's disease patients.
    2020 · Neurol Sci · Clinical study
  75. Relationship between the washout rate of I-123 MIBG scans and autonomic function in Parkinson's disease.
    2020 · PLoS One · Clinical study
  76. Isolated left adrenal medullary hyperplasia.
    2020 · J Cardiol Cases · Clinical study
  77. [123I]Metaiodobenzylguanidine (MIBG) Cardiac Scintigraphy and Automated Classification Techniques in Parkinsonian Disorders.
    2020 · Mol Imaging Biol · Clinical study
  78. Assessment of right ventricular sympathetic dysfunction in patients with arrhythmogenic right ventricular cardiomyopathy: An 123I-metaiodobenzylguanidine SPECT/CT study.
    2020 · J Nucl Cardiol · Clinical study
  79. Imaging cardiac innervation in hereditary transthyretin (ATTRm) amyloidosis: A marker for neuropathy or cardiomyopathy in case of heart failure?
    2020 · J Nucl Cardiol · Clinical study
  80. Analysis of quantitative [I-123] mIBG SPECT/CT in a phantom and in patients with neuroblastoma.
    2019 · EJNMMI Phys · Clinical study
  81. Impact of short-acting loop diuretic doses and cardiac sympathetic nerve abnormalities on outcomes of patients with reduced left ventricular function.
    2019 · Medicine (Baltimore) · Clinical study
  82. Clinical characteristics of elderly depressive patients with low metaiodobenzylguanidine uptake.
    2019 · Psychogeriatrics · Clinical study
  83. Striatal dopamine activity and myocardial 123I-metaiodobenzylguanidine uptake in early Parkinson's disease.
    2019 · Parkinsonism Relat Disord · Clinical study
  84. Focal 123I-MIBG Uptake in the Medial Segment of the Normal Liver.
    2019 · Clin Nucl Med · Clinical study
  85. Diffuse 123I-MIBG renal uptake in a patient with severe renal artery stenosis: A consequence of adrenergic activation.
    2019 · Rev Esp Med Nucl Imagen Mol (Engl Ed) · Clinical study
  86. Non-Val30Met mutation, septal hypertrophy, and cardiac denervation in patients with mutant transthyretin amyloidosis.
    2019 · ESC Heart Fail · Clinical study
  87. Cerebrospinal fluid 5-HIAA concentrations correlate with cardiac uptake of 123I-MIBG during myocardial scintigraphy in drug naïve Parkinson's disease.
    2018 · J Neural Transm (Vienna) · Clinical study
  88. [Decreased Uptake of Metaiodobenzylguanidine (MIBG) Myocardial Scintigraphy in a 64-year-old Female, Who Was Diagnosed as a Progressive Supranuclear Palsy].
    2018 · Brain Nerve · Clinical study
  89. Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy.
    2018 · Sleep · Clinical study
  90. Unusual Long Survival with a Giant Invasive Pheochromocytoma of an Incompatible Patient.
    2018 · Cureus · Clinical study
  91. Ageing effect on 18F-DOPA and 123I-MIBG uptake: a cross-sectional study.
    2018 · Nucl Med Commun · Clinical study
  92. Early diagnosis of Lewy body disease in patients with late-onset psychiatric disorders using clinical history of rapid eye movement sleep behavior disorder and [123 I]-metaiodobenzylguanidine cardiac scintigraphy.
    2018 · Psychiatry Clin Neurosci · Clinical study
  93. Is 123I-metaiodobenzylguanidine heart-to-mediastinum ratio dependent on age? From Japanese Society of Nuclear Medicine normal database.
    2018 · Ann Nucl Med · Clinical study
  94. Impairment of Iodine-123-Metaiodobenzylguanidine (123I-MIBG) Uptake in Patients with Pulmonary Artery Hypertension.
    2018 · Int Heart J · Clinical study
  95. Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease correlate with major autonomic symptoms?
    2006 · Parkinsonism Relat Disord · Clinical study
  96. Metaiodobenzylguanidine (MIBG) uptake in Parkinson's disease also decreases at thyroid.
    2005 · Ann Nucl Med · Clinical study
  97. [Evaluation of long-term prognosis in patients with heart failure: is cardiac imaging with iodine-123 metaiodobenzylguanidine useful?].
    1998 · J Cardiol · Clinical study
  98. Cervical Vertebral Metastasis Mimicking Thyroid Uptake on Planar 123 I-MIBG Images.
    2026 · Clin Nucl Med · Case report
  99. [A Case of Asymptomatic Paraganglioma of the Bladder].
    2026 · Hinyokika Kiyo · Case report
  100. A case of adrenal endothelial cyst (vascular type) with positive 123I-MIBG uptake.
    2026 · Urol Case Rep · Case report
  101. Normotensive functional para-aortic paraganglioma: A rare case report with surgical and histopathological correlation.
    2025 · Int J Surg Case Rep · Case report
  102. Idiopathic polyneuropathy with neurogenic autonomic failure - an early manifestation of Lewy body disease? a case report.
    2025 · BMC Neurol · Case report
  103. Giant Pheochromocytoma With Non-classical Symptoms: A Case Report to Expand Clinical Awareness.
    2025 · Cureus · Case report
  104. Sars-Cov-2 Infection as Catecholamin Crisis in Pheocreomocitoma: A Case Report.
    2025 · Endocr Metab Immune Disord Drug Targets · Case report
  105. Molecular Imaging in CANVAS: A Contribution for Differential Diagnosis?
    2024 · Mov Disord Clin Pract · Case report
  106. A Rare Case of Abnormal Diffuse Brain Uptake on an 123I MIBG Scan in a Patient With High-Risk Neuroblastoma.
    2024 · Clin Nucl Med · Case report
  107. Pheochromocytoma With High Adrenocorticotropic Hormone Production Capacity Without Pigmentation and Cushingoid Symptoms: A Case Report With a Literature Review.
    2024 · Cureus · Case report
  108. Effectiveness of 18F-FDG PET/CT in finding lung metastasis from a retroperitoneal paraganglioma.
    2024 · Asia Ocean J Nucl Med Biol · Case report
  109. Pitfalls in the diagnosis and treatment of a hypertensive patient with unilateral primary aldosteronism and contralateral pheochromocytoma: a case report.
    2023 · BMC Endocr Disord · Case report
  110. Dopamine-Secreting Pheochromocytoma and Paraganglioma.
    2021 · J Endocr Soc · Case report
  111. Expression of unfolded protein response markers in the pheochromocytoma with Waardenburg syndrome: a case report.
    2020 · BMC Endocr Disord · Case report
  112. Anti-Cholinergic Derangement of Cortical Metabolism on 18F-FDG PET in a Patient with Frontotemporal Lobar Degeneration Dementia: A Case of the TREDEM Registry.
    2020 · J Alzheimers Dis · Case report
  113. Multifocal Urinary Bladder Paragangliomas With Negative 68Ga-DOTATATE Uptake and Positive 123I-MIBG Uptake.
    2020 · Clin Nucl Med · Case report
  114. Metastatic pheochromocytoma to the pancreas diagnosed by endoscopic ultrasound-guided fine needle aspiration: A case report and review of literature.
    2020 · Diagn Cytopathol · Case report
  115. [PHEOCHROMOCYTOMA CRISIS WITH MIBG SCINTIGRAPHY NEGATIVE: A CASE REPORT].
    2019 · Nihon Hinyokika Gakkai Zasshi · Case report
  116. A Unique Case of Metastatic, Functional, Hereditary Paraganglioma Associated With an SDHC Germline Mutation.
    2018 · J Clin Endocrinol Metab · Case report

Need this precursor?We can point you to suppliers for [123I]MIBG, or handle the enquiry for you.

Get in touch

Quality control Preliminary - inferred from compound class

Ph. Eur. monograph
not verified No Ph. Eur. check is recorded for this entry.
USP monograph
not verified No USP check is recorded for this entry.
AppearancepHRCP HPLCRCP TLCHPLC UVRadionuclidic (HPGe)Half-lifeActivityEndotoxins (LAL)SterilityFilter integrityMolar activity
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); receptor ligand with a saturable target -> molar activity (rule); organic-phase radiosynthesis assumed from isotope/compound class, no synthesis data confirming it -> GC residual solvents (preliminary)

Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived

Setting up quality control?We can help you scope the equipment needed to release [123I]MIBG.

Get in touch

Notes

Added from reverse module search (stage 6); 3 article(s) with I-123. Also seen with I-131[1] (too few articles for own row). | Stage 28: added indication(s) car-sympathetic from consolidated missing-rubric review.
Ask a question